Antibe Therapeutics Inc(Pre-Merger) T.ATE

Dr. John Wallace

[Marky1]

This man is the guru of anti-inflammatoires GI science..He has published more than 400 peer reviewed papers...He has written more than 100 chapters on the topic of H2S technology....He is in the top  0.5% of the worlds top scientists receiving citations of his works ( that's the biography at the end of a study ) over 28,000 citations..He has given more than 500 lectures all over the world..
Lets think of all the work that he has done on ATB 346 since he invented it back around 2004.. An entire lifes hardwork all coming to a head! A Nobel Prize should be coming his way..
2021 will be the year for ATE ! 

The majority of his wealth, along with his buddy, Dan Legault rests on his ownership of ATE stock..They both deserve a hearty thank you from every shareholder..
At the end of the road we'll all reap the rewards of their hard work
GLTA

[drippingsnot]

His "Eureka" moment is why I am here. More than happy to thank them ... but ... let's wait for them to delivery the goods. : ) P.S.  Marky - you never finished the discussion you started (CEO).

[Marky1]

Which discussion are you referring to??  I've been in this company since August 2019 when Bob McWhirter chose it a top pick.   My shares are stored away in my vault of hopes and wishes.. everyone out there...We have a winner, we have the greatest drug invention since Acetaminophen ( not an NSAID ) The market cap should, and will be, as said in the BioPub, 600M$ USD which works

[Inthepez]

I agree Mark. But I wouldn’t too much weight to to what mcwhirter has to say. The fool didn’t even know about the liver enzymes, during th dockside chat on biopub. He asked why didn’t ATE disclose, that information during the Q&A portion.

[Canadian_101]

I for one can tell you Bob is right a lot more than wrong....he has helped me make so much money on a yearly basis its not funny, I can list at least 5 stocks I have had doubles or  triples on from his top picks or analysis , anyone to call him " a fool" speaks volumes about that persons IQ level. I am sure there are many investors who would agree with my expert opinion!!!! Good

[themagicbox]

Pez was obviously making a hyperbolic statement. But you sound pretty butt hurt. Also past performance, doesnt dictate future performance in business. But I am with Pez on the liver enzymes. Bobby is an idiot with respect to his understanding of ATE if he didnt know about the liver enzymes being disclosed.  Btw his nickname is Mcpumper. Thats why people like you buy and sell on his calls. He

[Canadian_101]

'Butt Head". how old are ya...18????   Just checked my portfolio of 60 stocks, and I  see 5 that Bob discussed 3 years ago on BNN and elsewhere that I still own today ( all of which are showing 100 percent growth or more) By the way take the time to review what he said on BNN ( 2.18 OF CLIP) he clearly discuss's the liver enzyme issue so he is aware of what occurred

[themagicbox]

Haha I actually wrote butthurt not butt head. Its your attention to detail and (in)ability to subtlety  that impresses ;) secondly, Pez was referencing the dockside chat on biopub, where mcpumper was asking why didnt ate disclose the liver enzymes issue. Retard question from mcpumper, that the entire panel unanimously said, thats not true. Also your link doesnt work haha.  Also

[TriumphSpitSix]

Someone needs to look up the definition of the word "hyperbole" to start with. Canadian_101 seems to have been speaking quite literally... nothing "hyperbolic" about it.  

[themagicbox]

It was in reference to Pez's comment about him being a fool. Obviously mcpumper isnt a fool but was foolish in his question. Just go home. 

[themagicbox]

Hey Marky. whats going on man? I saw some of your comments on CEO. You getting cold feet. Your faith seems to have shaken a bit haha.\

[Marky1]

Nice to hear from you Magic! Missed your comments...always great reading...No, I am still very positive on ATE....I believe in the chemistry, the H2S technology, in management...but...i was extremely disappointed by the June PR bringing to SP from .89$ to under .60$....I feel that they really mucked it up....They should, I think, just left off the 150mg dosage...200 mg and 250mg were that's

[drippingsnot]

That's a good point Marky but I don't think it would have solved anything. If you left out 150 mg, FDA would likely ask ... How low can you go before it fails? We would probably be in the same position, doing a Phase2/3. Back to my original question from a few weeks ago ... In Phase 2/3, we obviously get to look at the PART 1 data to determine the dose. It's like a window into our

[themagicbox]

I can relate man. Im just curious why they didnt power the 150mg from the get go for statistical significance. Was it money? was it taking too long? Recruiting issues? They didnt really address this issue head on. They definitely mucked up on many fronts.  But going off of MUGs last comment, they want to have the least amount of SEs at the minimal/maximal analgesic efficacy, so really its an

[drippingsnot]

I think I heard Dan or Joe say they didn’t think 150 mg was going to work - Surprise !!!!!  hahaha. So ... if they powered 150 mg and it succeeded, we’d be in the same situation. Oh well !